Continuous Glucose Monitors May Reveal Heart Risk

Can continuous glucose monitors detect hidden heart risk?

Fasting plasma glucose and HbA1c remain standard tools for detecting prediabetes and diabetes, but each provides a limited view. Fasting glucose reflects one moment, while HbA1c estimates average glucose exposure over roughly two to three months. Neither test directly shows how sharply glucose rises after meals, how long elevations persist or how much levels fluctuate throughout the day.

Continuous glucose monitors measure glucose in the fluid between cells at frequent intervals, producing a detailed daily profile. Researchers are examining whether features such as repeated post-meal peaks, prolonged elevations and high glucose variability correlate with insulin resistance, vascular dysfunction or other cardiovascular risk factors in people whose conventional results remain below diabetes thresholds. An association would identify a potential risk marker, not prove that glucose fluctuations directly cause heart disease.

Why might glucose variability affect cardiovascular health?

Persistently elevated blood glucose can damage blood vessels, and diabetes is a well-established cardiovascular risk factor. Shorter glucose excursions are less clearly understood. Experimental and observational research suggests that pronounced fluctuations may be linked to oxidative stress, endothelial dysfunction and inflammatory signaling, but the clinical importance of these mechanisms in adults without diabetes remains uncertain.

CGM patterns can also be influenced by meal composition, physical activity, sleep, illness, medications and sensor performance. A concerning trace therefore cannot reveal its cause by itself. Researchers must determine whether CGM adds useful information beyond established measures such as blood pressure, cholesterol, smoking status, family history, kidney health and laboratory glucose testing.

Should people without diabetes use a glucose monitor?

Continuous glucose monitoring is an established diabetes-management technology, particularly for people using insulin. Its broader use in people without diabetes is still an evolving research area. Consumer access does not mean that every rise after eating is abnormal; glucose naturally changes during the day, and interpretation thresholds developed for diabetes care may not apply to otherwise healthy adults.

People concerned about cardiometabolic risk should begin with validated assessment: blood pressure measurement, lipid testing, evaluation of smoking and family history, and appropriate screening for diabetes or prediabetes. A clinician may recommend fasting plasma glucose, HbA1c or an oral glucose tolerance test depending on the circumstances. CGM findings should not prompt restrictive diets, medication changes or self-diagnosis without professional interpretation.